Taken together, our study elucidates the role of SUCLG2 in mitochondrial dysfunction and clarifies the mechanism of the succinylation‐mediated protein homeostasis of SUCLG2 in LUAD, thereby providing a theoretical basis for developing anti‐tumor drugs by targeting SUCLG2. This evidence concerns the gene SUCLG2 and neoplasm.